Biofrontera targets cash flow breakeven in 2026 while aiming for 80%-85% gross margin
Biofrontera Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $0.95
-20% in 7d after detection
Post-detection moves
1h
—
1d
-19%
3d
-18%
7d
-20%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS